Novel pebtide and gene vaccination approaches to modulate lupus nephritis.

被引：0
|
作者：
Singh, RR [1 ]
Yang, JQ [1 ]
Fan, GC [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：369A / 370A
页数：2
相关论文
共 50 条
  • [41] Lupus nephritis. How latest insights into its pathogenesis promote novel therapies
    Kulkarni, Onkar P.
    Anders, Hans-Joachim
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (05) : 457 - 465
  • [42] The effective use of Mycophenolate mofetil in the treatment of lupus nephritis.
    Kingdon, EJ
    Psimenou, E
    Sweny, P
    Burns, A
    KIDNEY INTERNATIONAL, 1999, 55 (06) : 2563 - 2563
  • [43] Current therapy of lupus nephritis.: Which is the best option?
    Silva-Fernandez, L.
    Andreu-Sanchez, J. L.
    Ginzler, E. A.
    REVISTA CLINICA ESPANOLA, 2008, 208 (03): : 138 - 141
  • [44] B lymphocytes and plasma cells in human lupus nephritis.
    Guttikonda, Riteesha
    Chang, Anthony
    Liu, Ni
    Henderson, Scott G.
    Clark, Marcus R.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4029 - 4029
  • [45] Disease Specific Quality of Life in Patients with Lupus Nephritis.
    Mok, Chi Chiu
    Toloza, Sergio
    Goker, Berna
    Clarke, Ann E.
    Navarra, S.
    Wallace, Daniel J.
    Weisman, Michael H.
    Jolly, Meenakshi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S736 - S737
  • [46] Further description of early clinically silent lupus nephritis.
    Zaboleta-Lanz, Mercedes
    Munoz, Luis
    Tapanes, Francisco
    Daboin, Iraida
    Pinto, Jose
    Vargas-Arenas, Rafael
    Barrios, Yadira
    Bianco, Nicolas
    CLINICAL IMMUNOLOGY, 2006, 119 : S69 - S69
  • [47] Pharmacogenetic determinant of cyclophosphamide therapy in patients with lupus nephritis.
    Arefayene, M
    Desta, Z
    Takada, K
    Yarboro, C
    Carrero, H
    Illei, G
    Flockhart, DA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P97 - P97
  • [48] Increase of plasma and urine MIF in SLE and lupus nephritis.
    Seo, YI
    Park, MK
    Cho, ML
    Hong, JH
    Kim, HL
    Park, KS
    Yoon, CH
    Kim, WU
    Hong, YS
    Lee, SH
    Park, SH
    Cho, CS
    Kim, HY
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S196 - S196
  • [49] Antiphospholipid antibodies in lupus nephritis. A clinical and pathological study
    Savio, V.
    Alba, P.
    Gobbi, C.
    Herrero, M.
    Amione, S.
    Ghirardi, G.
    Babini, A.
    Exeni, I.
    Albiero, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 137 - 137
  • [50] Microarray analysis of glomerular gene expression in mouse lupus nephritis. Effects of glucocorticoid.
    Teramoto, Kae
    Negoro, Nobuo
    Kitamoto, Kouichirou
    Hirose, Masaaki
    Iwai, Tomoaki
    Kamura, Mikio
    Miura, Katsuyuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 217P - 217P
12345